BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10606966)

  • 1. Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides.
    Deng YJ; Notkins AL
    Clin Exp Immunol; 2000 Jan; 119(1):69-76. PubMed ID: 10606966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.
    Ditzel HJ; Itoh K; Burton DR
    J Immunol; 1996 Jul; 157(2):739-49. PubMed ID: 8752924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.
    Cheung SC; Takeda S; Notkins AL
    Clin Exp Immunol; 1995 Aug; 101(2):383-6. PubMed ID: 7648724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3.
    Edwards MR; Brouwer W; Choi CH; Ruhno J; Ward RL; Collins AM
    J Immunol; 2002 Jun; 168(12):6305-13. PubMed ID: 12055246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.
    Martin T; Crouzier R; Weber JC; Kipps TJ; Pasquali JL
    J Immunol; 1994 Jun; 152(12):5988-96. PubMed ID: 8207223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of Fab-ssDNA interactions: contribution of heavy chain complementarity determining region 3.
    Komissarov AA; Deutscher SL
    Biochemistry; 1999 Nov; 38(44):14631-7. PubMed ID: 10545187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amino acid substitutions in the heavy chain CDR3 of an autoantibody on its reactivity.
    Adib-Conquy M; Gilbert M; Avrameas S
    Int Immunol; 1998 Mar; 10(3):341-6. PubMed ID: 9576622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
    Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
    Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection.
    Ikematsu H; Kasaian MT; Schettino EW; Casali P
    J Immunol; 1993 Oct; 151(7):3604-16. PubMed ID: 8376796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen.
    Potter KN; Hobby P; Klijn S; Stevenson FK; Sutton BJ
    J Immunol; 2002 Oct; 169(7):3777-82. PubMed ID: 12244172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.
    D'Angelo S; Ferrara F; Naranjo L; Erasmus MF; Hraber P; Bradbury ARM
    Front Immunol; 2018; 9():395. PubMed ID: 29568296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
    Zhang M; Majid A; Bardwell P; Vee C; Davidson A
    J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus.
    Kasaian MT; Ikematsu H; Balow JE; Casali P
    J Immunol; 1994 Mar; 152(6):3137-51. PubMed ID: 8144908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
    Crouzier R; Martin T; Pasquali JL
    J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altering the fine specificity of an anti-Legionella single chain antibody by a single amino acid insertion.
    McCarthy BJ; Hill AS
    J Immunol Methods; 2001 May; 251(1-2):137-49. PubMed ID: 11292489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Ig heavy chain CDR3 regions in adult bone marrow pre-B cells display an adult phenotype of diversity: evidence for structural selection of DH amino acid sequences.
    Raaphorst FM; Raman CS; Tami J; Fischbach M; Sanz I
    Int Immunol; 1997 Oct; 9(10):1503-15. PubMed ID: 9352355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structure of eight human autoreactive monoclonal antibodies.
    Aguilera I; Melero J; Nuñez-Roldan A; Sanchez B
    Immunology; 2001 Mar; 102(3):273-80. PubMed ID: 11298825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse binding site structures revealed in homology models of polyreactive immunoglobulins.
    Ramsland PA; Guddat LW; Edmundson AB; Raison RL
    J Comput Aided Mol Des; 1997 Sep; 11(5):453-61. PubMed ID: 9385549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.